Metastatic Breast Cancer With HER2 Positive
2 clinical trials · Condition
◉ Watch Metastatic Breast Cancer With HER2 Positive
| Record | Firm | Date |
|---|---|---|
| SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer (NCT07132242) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-08-30 |
| Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer (NCT03617341) | Yonsei University | 2018-10-02 |
Track Metastatic Breast Cancer With HER2 Positive automatically
Every clearance here is in the API, with alerts when new ones post.